Moderna

American biotechnology company

Moderna ▸ Facts ▸ Comments ▸ News ▸ Videos

Moderna is an American biotechnology company focused on drug discovery, drug development, and vaccine technologies based exclusively on messenger RNA (mRNA). It is headquartered in Cambridge, Massachusetts. The Moderna technology platform is to insert synthetic mRNA into living cells that would reprogram the cells to develop immune responses, rather than being created externally and injected as with conventional medicines. It is a novel technique abandoned by several large pharmaceutical and biotechnology companies that were unable to overcome the side effects of inserting RNA into cells. As of May 2020, no mRNA drug has been approved for human use.

0 shares	Share Tweet Save Post Send



Moderna shares jump on U.S. vaccine deal Shares of Moderna jumped before paring their gains Wednesday after analysts said a $1.5 billion coronavirus vaccine supply agreement with the U.S. government could lead to similar deals with other.. Credit: Reuters Studio Duration: 01:09Published 23 hours ago

Dow Jumps 270 Points On Wednesday, US stocks rose. Investors reacted to positive coronavirus vaccine news. Shares of Moderna spiked after President Trump announced the US government will by 100 million doses of its.. Credit: Wochit News Duration: 00:25Published 1 day ago

Trump inks Moderna deal for 100 mln vaccine doses The United States has penned an agreement with drugmaker Moderna Inc to acquire 100 million doses of its potential COVID-19 vaccine, U.S. President Donald Trump said on Tuesday. Credit: Reuters Studio Duration: 01:29Published 2 days ago

Chinese hackers targeted vaccine firm Moderna Hackers linked to China's government targeted biotech company Moderna Inc, a leading U.S.-based coronavirus vaccine research developer, earlier this year in a bid to steal valuable data, according to a.. Credit: Reuters Studio Duration: 01:36Published 2 weeks ago

First Phase 3 Coronavirus Vaccine Candidate Begins Testing in US The experimental vaccine, developed by Moderna and the National Institute of Allergy and Infectious Diseases, began Phase 3 trials on Monday. Credit: Cover Video STUDIO Duration: 01:04Published 2 weeks ago

Moderna's COVID vaccine enters late-stage trial Moderna said on Monday it has started a U.S. government-backed late-stage trial for its COVID-19 vaccine candidate, the first to be implemented under the Trump administration's Operation Warp Speed.. Credit: Reuters Studio Duration: 00:55Published 2 weeks ago

Possible COVID-19 Vaccine Shown To Induce Strong Immune Response Moderna has announced that a COVID-19 vaccine it is developing has shown promise. The U.S. biotech company says its vaccine has induced a "rapid and strong" immune response against the virus. According.. Credit: Wochit News Duration: 00:32Published on July 15, 2020

Early Trials For Coronavirus Vaccine Show "Promise" A COVID-19 vaccine has been found to induce immune responses in some volunteers. The vaccine was developed by Moderna and the National Institutes of Health reports CNN. Immune responses were detected.. Credit: Wochit News Duration: 00:42Published on July 15, 2020

Early results show Moderna vaccine is safe Moderna's experimental vaccine for COVID-19 showed it was safe and provoked immune responses in all 45 healthy volunteers in an ongoing early-stage study, U.S. researchers reported on Tuesday. Libby.. Credit: Reuters Studio Duration: 01:35Published on July 15, 2020

Sanofi eyes vaccine approval by early 2021 French drugmaker Sanofi expects to get approval for the potential coronavirus vaccine it is developing with GlaxoSmithKline by the first half of next year. Francis Maguire reports. Credit: Reuters Studio Duration: 01:13Published on June 23, 2020

You Might Like

Moderna's virus vaccine costs far more than rival treatments Drugmaker is charging $32 to $37 for initial doses, more than triple the cost of other vaccines being tested. CBS News - Published 1 week ago
We can’t skip steps on the road to a COVID-19 vaccine Photo by Blake Nissen for The Boston Globe via Getty Images The pharmaceutical company Moderna started the last, longest step in the process of testing its COVID-19 vaccine candidate at the end of.. The Verge - Published 1 week ago
Poll: If the vaccine is approved, will people actually take it? There’s been plenty of progress lately in the hunt for a viable vaccine to protect people from the novel coronavirus. Both the Oxford vaccine and the Moderna version have entered... WorldNews - Published 2 weeks ago

Moderna Vaccine Test in Monkeys Shows Promise This coronavirus vaccine developed by government researchers and Moderna enabled the animals to quickly clear the infection from their lungs. NYTimes.com - Published 2 weeks ago
Detroit health system seeks vaccine study subjects A Detroit-area hospital system is looking for up to 5,000 volunteers for a COVID-19 vaccine study. Henry Ford Health System is working with the National Institutes of Health and Moderna Inc., with.. USATODAY.com - Published 2 weeks ago
Largest COVID-19 vaccine study underway in US The world's biggest COVID-19 vaccine test got underway Monday with the first of 30,000 planned volunteers. The experimental vaccine is made by the National Institutes of Health and Moderna Inc. It's.. USATODAY.com - Published 2 weeks ago

Some Vaccine Makers Say They Plan to Profit From Coronavirus Vaccine Moderna, which is receiving $483 million from the U.S. government, told lawmakers it would not sell its vaccine at cost. Pfizer has said it would also profit, but has so far taken no government money. NYTimes.com - Published 3 weeks ago
Covid-19 vaccine developed by US biotech firm Moderna enters final stage trial US biotech firm Moderna said Tuesday it would enter the final stage of human trials for its COVID-19 vaccine on July 27, to test how well it protects people in the real world. ...... WorldNews - Published on July 15, 2020
Moderna's COVID vaccine candidate appears to be safe and provide some immunity, new data from early trial shows It's too early to say if the vaccine candidate can protect someone from the coronavirus that causes COVID-19, but early trials are encouraging. USATODAY.com - Published on July 14, 2020
Moderna rally loses steam over COVID-19 vaccine worries Shares of biotechs racing to make coronavirus vaccines, including Moderna Inc , fell about 10% on Wednesday, as investor concerns grew about the prospects of the experimental products that are still in.. Reuters - Published on May 27, 2020

How Upbeat Vaccine News Fueled a Stock Surge, and an Uproar The desperate hunt for treatments and vaccines has changed how researchers, regulators, drug companies like Moderna, investors and journalists do their jobs. NYTimes.com - Published on May 23, 2020
S&P stumbles as Moderna sinks on report questioning trial results The S&P 500 closed lower on Tuesday, as investors focused on a report questioning Moderna's recent coronavirus vaccine early-stage trial results, wiping out modest gains on the benchmark index in the.. Reuters - Published on May 19, 2020
This Professor Was One of the First Investors in Vaccine-Maker Moderna. He’s Now Worth Nearly $1 Billion Another early investor of Moderna is on the cusp of owning a stake worth at least $1 billion after the biotech firm reported encouraging early trial results for an experimental Covid-19 vaccine. The.. WorldNews - Published on May 19, 2020	Coronavirus Briefing: What Happened Today A vaccine produced by Moderna appeared to be safe and effective in its first human trial. NYTimes.com - Published on May 19, 2020
Coronavirus vaccine from Moderna appears safe, shows promise in data from eight people Moderna Inc's experimental COVID-19 vaccine, the first to be tested in the United States, produced protective antibodies in a small group of healthy volunteers, according to very early data released by.. Reuters - Published on May 18, 2020	Moderna's possible coronavirus vaccine delivers preliminary but promising data Moderna and Oxford COVID-19 vaccine candidates have shown promise according to new data -- but it's very preliminary. USATODAY.com - Published on May 18, 2020
Moderna's COVID-19 vaccine shows early promise; shares soar Early data from Moderna Inc's COVID-19 vaccine, the first to be tested in the United States, showed that it produced protective antibodies in a small group of healthy volunteers, the company said on.. Reuters - Published on May 18, 2020	Stocks rebound as positive Moderna vaccine trial boosts optimism for economic recovery Stocks bounced back Monday on optimism the U.S. economy may start to recover from the coronavirus pandemic after drugmaker Moderna released promising early results for a vaccine. USATODAY.com - Published on May 18, 2020
Futures jump on promising data for COVID-19 vaccine U.S. stocks futures jumped on Monday after Moderna Inc said its experimental vaccine for COVID-19 showed promise in early trials and that it was looking to advance the vaccine into late-stage trials in.. Reuters - Published on May 18, 2020	Moderna Gets OK to Start Larger Trial for a Coronavirus Vaccine The company announced that the Food and Drug Administration had cleared its application to proceed to a clinical trial involving about 600 people. NYTimes.com - Published on May 7, 2020
J&J, Moderna sign deals with U.S. to produce huge quantity of possible coronavirus vaccines The U.S. government has cut deals with Johnson & Johnson and Moderna Inc and said it is in talks with at least two other companies to prepare them to produce massive quantities of coronavirus vaccines.. Reuters - Published on March 30, 2020	Drugmakers chase vaccine as coronavirus spreads globally The National Institutes of Health has partnered with a Boston-area company, Moderna, on a vaccine targeting the novel coronavirus. USATODAY.com - Published on January 25, 2020
Lovers of Moderna skeletons holding hands were both men The male skeletons, buried in Roman times, have been holding hands for around 1,500 years. BBC News - Published on September 12, 2019